Affinity Asset Advisors, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.

Quarter-by-quarter ownership
Affinity Asset Advisors, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2021$7,500,000
+111.6%
750,000
+200.0%
1.89%
+49.3%
Q2 2021$3,545,000
-5.0%
250,000
+9.9%
1.27%
+0.1%
Q1 2021$3,733,000
-18.0%
227,500
+3.4%
1.27%
-47.5%
Q4 2020$4,554,000220,0002.41%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders